Subhayan Sur
Impact in
- Drug Discovery top 10%
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 5
- Cancer, Hypoxia, and Metabolism 2
-
- Medicinal Plant Research 8
- Co-authors
- Ratna B. Ray (17 shared papers)Chinmay Kumar Panda (10 shared papers)Robert Steele (14 shared papers)Debolina Pal (8 shared papers)Anup Kumar Roy (5 shared papers)Ranjit Ray (5 shared papers)Hiroshi Nakanishi (3 shared papers)Timothy Scott Isbell (3 shared papers)
- Journals
- Cancers (3 papers)Hepatology (2 papers)Molecular Carcinogenesis (2 papers)BMC Cancer (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Subhayan Sur
35 papers receiving 910 citations
Peers
Comparison fields: 5 of 82
- Drug Discovery 7
- Cancer Research 242
- Hepatology 49
- Otorhinolaryngology 30
- Pathology and Forensic Medicine 86
Countries citing papers authored by Subhayan Sur
This map shows the geographic impact of Subhayan Sur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhayan Sur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhayan Sur more than expected).
Fields of papers citing papers by Subhayan Sur
This network shows the impact of papers produced by Subhayan Sur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhayan Sur. The network helps show where Subhayan Sur may publish in the future.
Co-authors
The 25 scholars most cited alongside Subhayan Sur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 86 | |
| 2 | 2019 | 79 | |
| 3 | 2020 | 71 | |
| 4 | 2019 | 61 | |
| 5 | 2021 | 54 | |
| 6 | 2016 | 52 | |
| 7 | 2015 | 49 | |
| 8 | 2012 | 47 | |
| 9 | 2017 | 40 | |
| 10 | 2022 | 39 | |
| 11 | 2018 | 35 | |
| 12 | 2019 | 32 | |
| 13 | 2020 | 32 | |
| 14 | 2021 | 28 | |
| 15 | 2020 | 27 | |
| 16 | 2019 | 26 | |
| 17 | 2018 | 24 | |
| 18 | 2021 | 18 | |
| 19 | 2020 | 16 | |
| 20 | 2023 | 15 |
About Subhayan Sur
Subhayan Sur is a scholar working on Cancer Research, Plant Science, Hepatology, Pathology and Forensic Medicine and Molecular Biology, having authored 36 papers that have together received 927 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Medicinal Plant Research (8 papers), MicroRNA in disease regulation (5 papers), Advances in Cucurbitaceae Research (4 papers), Tea Polyphenols and Effects (4 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Drug Discovery (7 citations), Cancer Research (242 citations), Hepatology (49 citations), Otorhinolaryngology (30 citations) and Pathology and Forensic Medicine (86 citations). Subhayan Sur has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Ratna B. Ray, Chinmay Kumar Panda, Robert Steele, Debolina Pal, Anup Kumar Roy, Ranjit Ray, Hiroshi Nakanishi, Timothy Scott Isbell, Suvra Mandal and Mst. Mousumi Khatun. Their work appears in journals such as Cancers, Hepatology, Molecular Carcinogenesis, BMC Cancer and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.